Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e23564
Abstract: e23564Background: Activity of temozolomide (TEM) and irinotecan (IRI) in recurrent Ewing sarcoma (EWS) was demonstrated. Few data are available on TEMIRI use upfront. Biological predictive factors ...
read more here.
Keywords:
sarcoma translational;
temozolomide upfront;
ewing sarcoma;
irinotecan temozolomide ... See more keywords